Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 200, Issue 9, Pages 1452-1455Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/606026
Keywords
-
Categories
Funding
- University of Washington
- National Institute of Allergy and Infectious Diseases [R01-AI38383]
Ask authors/readers for more resources
We sought to determine whether oral fluid can be used to assess serum human papillomavirus (HPV) antibody status by enrolling women who had received a prophylactic HPV-16 vaccine in a new follow-up study. After the prophylactic HPV-6/11/16/18 vaccine was licensed in the United States, we administered it to consenting participants. With serologic findings used as the reference standard, The sensitivity of oral fluid was 49.6% (95% confidence interval [CI], 42.0%-57.3%) before and 100% (95% CI, 92.0%-100%) after administration of the quadrivalent vaccine. Oral fluid may have the potential to be used for monitoring of prophylactic HPV vaccines in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available